BIONOTE to Launch Vcheck Canine TnI Next Month

 Bionote, a leading veterinary diagnostic company based in Korea, is introducing a new biomarker, TnI, as a part of the Vcheck series.


Vcheck Canine TnI is an in vitro diagnostic test kit for the quantitative measurement of cardiac Troponin I (TnI) concentration in canine serum. This test kit precisely quantifies the degree of elevation in TnI levels in dogs.





Troponin consists of 3 subunits (troponin I, T, and C) which together function as the molecular switch of cardiomyocyte contraction. Among them, cardiac Troponin I (TnI) is a sensitive and specific circulating marker of cardiac injury for dogs. 


Cardiac injury causes the release of TnI into the circulation, where its concentration is correlated to the severity of the damage.


Vcheck Canine TnI can provide important diagnostic and prognostic information in patients with cardiovascular or non-cardiac diseases as a cardiac injury marker of choice. 


A combined measurement of TnI and NT-proBNP is prognostically superior to measuring each alone in dogs with mitral valve disease (MMVD). NT-proBNP is also one of the Vcheck biomarkers.


Vcheck Canine TnI: This one-step test procedure is easy to follow and provides fast results within 10 minutes using serum samples from dogs.


Meanwhile, Vcheck Feline TnI, which measures cardiac TnI in feline blood, will be released later this year.




If you are interested in Vcheck Canine TnI, please contact your local distributor or mail to [].